Impact of smoking on the response to treatment of thyroid associated ophthalmopathy

British Journal of Ophthalmology

Volumn 87, Issue 6, 2003, Pages 773-776

  Eckstein, Anja ^a   Quadbeck, B ^b   Mueller, G ^c   Rettenmeier, A W ^a   Hoermann, R ^b   Mann, K ^b   Steuhl, P ^a   Esser, J ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b Division of Endocrinology   (Germany)

^c Department of Hygiene and Occupational Medicine ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ETHYLENE DERIVATIVE; FLUOCORTOLONE; HEMOGLOBIN; N 2 HYDROXYETHYLVALINE; STEROID; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CIGARETTE SMOKING; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DOSE RESPONSE; ENDOCRINE OPHTHALMOPATHY; EVALUATION; EYE DISEASE; EYE MOVEMENT; FEMALE; FOLLOW UP; GRAVES DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARAMETER; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOTHERAPY; SCORING SYSTEM; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTI-INFLAMMATORY AGENTS; COMBINED MODALITY THERAPY; FEMALE; FLUDROCORTISONE; GRAVES DISEASE; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; OCULAR MOTILITY DISORDERS; PROSPECTIVE STUDIES; SMOKING; TREATMENT OUTCOME; VALINE;

EID: 0038018256     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.87.6.773     Document Type: Article

References (21)

1. Hagg E, Asplund K. Is endocrine ophthalmopathy related to smoking? BMJ 1987;295:634-5.
2. Bartalena L, Martino E, Marcocci C, et al. More on smoking habits and Graves' ophthalmopathy. J Endocrinol Invest 1989;12:733-7.
3. Balazs C, Stenszky V, Farid NR. Association between Graves' ophthalmopathy and smoking. Lancet 1990;336:754.
4. Shine B, Fells P, Edwards OM, et al. Association between Graves' ophthalmopathy and smoking. Lancet 1990;335:1261-3.
5. Tellez M, Cooper J, Edmonds C. Graves' ophthalmopathy in relation to cigarette smoking and ethnic origin. Clin Endocrinol 1992;36:291-4.
6. Prummel MF, Wiersinga WM. Smoking and risk of Graves' disease. JAMA 1993;269:479-482.
7. Winsa B, Mandahl A, Karlsson FA. Graves' disease, endocrine ophthalmopathy and smoking. Acta Endocrinol (Copenh) 1993;128:156-60.
8. Pfeilschifter J, Ziegler R. Smoking and endocrine ophthalmopathy:impact of smoking severity and current vs lifetime cigarette consumption. Clin Endocrinol 1996;45:477-81.
9. Bartalena L, Marcocci C, Tanda ML, et al. Cigarette smoking and treatment outcomes in Graves' ophthalmopathy. Ann Intern Med 1998;129:632-5.
10. Quadbeck B, Kalinski R, Eckstein A, et al. Lack of influence of smoking on the course of Graves' ophthalmopathy under antiinflammatory therapy. 71th Annual Meeting of the American Thyroid Association. Portland, Oregon, USA. The Proceedings of the ATA, 1998:S-83.
11. Farmer PB, Cordero R, Autrup H. Monitoring human exposure to 2-hydroxyethylating carcinogens. Environ Health Perspect 1996;104(Suppl 3):449-52.
12. Bailey E, Brooks AGF, Dollery CT, et al. Hydroxyethylvaline adduct formation in haemoglobin as a biological monitor of cigarette smoke intake. Arch Toxicol 1988;62:247-53.
13. Mourits MP, Prummel MF, Wiersinga WM, et al. Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy. Clin Endocrinol 1997;47:9-14.
14. Van Sittert NJ. N-2-Cyanoethylvaline, N-2-hydroxyethylvaline, N-methylvaline (as evidence of exposure to acrylonitrile, ethylene oxide as well as methylating agents). In: Angerer J, Schaller KH, eds (on behalf of the Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area of the Deutsche Forschungsgemeinschaft). Analyses of hazardous substances in biological materials. Vol 5 VCH Verlagsgesellschaft Weinheim, 1997:181-210.
15. Bona R, Vincenti M, Meineri V, et al. Formation of N-(2-hydroxyethyl)valine due to exposure to ethylene oxide via tobacco smoke:A risk factor for onset of cancer. Environ Res 1999;81:62-71.
16. Utiger RD. Effects of smoking on thyroid function. Eur J Endocrinol 1998;138:368-9.
17. Muller B, Zulewski H, Huber P, et al. Impaired action of thyroid hormone associated with smoking in women with hypothyroidism. N Engl J Med 1995;333:964-9.
18. Metcalfe RA, Weetman AP. Stimulation of extraocular muscle fibroblasts by cytokines and hypoxia:possible role in thyroid-associated ophthalmopathy. Clin Endocrinol 1994;40:67-72.
19. Schwartz J, Weiss ST. Cigarette smoking and peripheral blood leukocyte differentials. Ann Epidemiol 1994;4:236-42.
20. McAllister-Sistilli CG, Caggiula AR, et al. The effects of nicotine on the immune system. Psychoneuroendocrinology 1998;23:175-87.
21. Hofbauer LC, Muhlberg T, Koenig A, et al. Soluble interleukin-1 receptor antagonist serum levels in smokers and nonsmokers with Graves' ophthalmopathy undergoing orbital radiotherapy. J Clin Endocrinol Metab 1997;82:2244-7.